ccuray is a radiation oncology company. Co.'s principal radiosurgery product is the CyberKnife® Robotic Radiosurgery Systems, which is designed to combine continual image guidance technology with a compact linear accelerator. Co.'s principal radiation therapy product, the TomoTherapy® System, operates on a ring gantry and combines integrated computed tomography imaging with intensity modulated radiation therapy, which is designed to deliver radiation treatments while reducing radiation exposure to surrounding tissue. Co. also provides optional hardware and software, technical enhancements and upgrades to the TomoTherapy System, as well as service contracts and training.
Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Service. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20
minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.